Skip to content

13F-HR filed by Commodore Capital LP

Commodore Capital LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 32 holding rows worth $656,834,859.

Accession
0001831942-23-000007
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 32 entries on the cover page, a total value of $656,834,859 stated on the cover page (in dollars after the unit check, H1), rows summing to $656,834,859 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
XENON PHARMACEUTICALS INC COM98420N105Stock1,845,000$66,032,550dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM2,189,659$55,704,925dollars as filed
MERUS N VN5749R100COM2,950,000$54,280,000dollars as filed
COGENT BIOSCIENCES INC19240Q201COM4,772,421$51,494,423dollars as filed
BELLUS HEALTH INC NEW07987C204COM6,579,359$47,371,385dollars as filed
AMBRX BIOPHARMA, INC. SPONSORED ADR02290A102COM4,803,447$42,846,747dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock1,731,365$37,916,894dollars as filed
AKERO THERAPEUTICS INC00973Y108COM790,000$30,225,400dollars as filed
NUVALENT INC COM670703107Stock1,075,000$28,046,750dollars as filed
IMMUNOVANT INC45258J102COM1,440,999$22,349,894dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK2,824,029$21,914,465dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM853,884$18,034,030dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW495,823$17,839,712dollars as filed
CYMABAY THERAPEUTICS INC23257D103COM2,025,000$17,658,000dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK1,835,000$15,175,450dollars as filed
KURA ONCOLOGY INC COM50127T109Stock1,204,958$14,736,636dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM575,000$14,605,000dollars as filed
CELCUITY INC15102K100COM1,390,772$14,255,413dollars as filed
PROMETHEUS BIOSCIENCES INC74349U108COM127,156$13,646,382dollars as filed
ALPINE IMMUNE SCIENCES INC02083G100COM1,325,000$10,229,000dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock739,661$9,889,268dollars as filed
AVIDITY BIOSCIENCES INC COM05370A108Stock590,705$9,067,322dollars as filed
ENANTA PHARMACEUTICALS INC29251M106COM217,253$8,785,711dollars as filed
ALLAKOS INC01671P100COM1,900,000$8,455,000dollars as filed
VAXCYTE INC COM92243G108Stock200,000$7,496,000dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock635,000$5,137,150dollars as filed
THIRD HARMONIC BIO INC88427A107COM993,294$4,092,371dollars as filed
Adverum Biotechnologies, Inc.00773U108Common Stock5,000,000$3,587,000dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM312,553$2,456,667dollars as filed
REZOLUTE INC76200L309COMMON STOCK898,267$1,724,673dollars as filed
ACUMEN PHARMACEUTICALS INC00509G209CMN400,000$1,624,000dollars as filed
DBV TECHNOLOGIES S A23306J101ADR92,687$156,641dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001831942-23-000007this filing2023-05-15acceptance time not in the bulk data set